Navigation Links
Kodak in vivo imaging system: precise coregistration of molecular imaging with anatomical X-ray imaging in animals

Kodak Molecular Imaging Systems introduces a line of small-animal in vivo imaging instruments that provide a new level of molecular signal localization in live animals. The Image Station In-Vivo FX allows precise multi-modal coregistration of optical or radioisotopic molecular images with high-resolution anatomical X-ray images in animals


Traditional research on disease mechanisms using animal models has relied mainly on the detection of morphological changes of the diseased tissues, with physical measurements and anatomical imaging or on the excision and pathological study of the tissues of interest. These methods often require long time periods for measurable changes to occur and require a large number of animal cohorts as multiple animals are often sacrificed at each time point for histological testing.

Over the last few years, exciting new molecular imaging agents have emerged from research laboratories that allow highly specific fluorescence-, luminescence- and radioisotope-based imaging of disease processes at the molecular level within living animals. These in vivo molecular imaging agents provide the potential for rapid detection of specific molecular and metabolic changes within target tissues in animals (or humans) long before morphologic changes can be detected. In addition, these molecular changes can be monitored in vivo without sacrificing the animal, resulting in lower cost, time savings and improved data by using the same live animal for continued studies.


The need for multimodal imaging
One major advantage of optical molecular imaging over anatomical imaging is the use of dark-field imaging methods that allow high levels of target signal over the surrounding background signal. Dark-field contrast, however, does not typically provide the appropriate contextual anatomic information for useful localization of the molecular imaging signals within the animal. Limited anatomic context of darkfield agents has been provided using digital imaging overlay techniques in which the dark-field contrast is superimposed on a reflection image of an experimental animal.

Although the overlay methods are beneficial, repeated imaging of the same animal in different imaging sessions often results in misinterpretation of the signal localization as animal repositioning is difficult. The white-light reference image may be suitable for localization of large tumor masses, but lacks the anatomical context required for repeatedly localizing smaller signals of interest and/or mapping the molecular signals to bones or other anatomical structures within the animal.

Hoping to realize the full potential of the dark-field molecular imaging agents, researchers are beginning to apply multimodal instrumentation that combines dark-field contrast with penetrating radiographic anatomical imaging in one system.


Kodak Image Station In-Vivo F/FX
Kodak Molecular Imaging Systems has recently introduced a line of in vivo small-animal imaging systems, including a model that allows the capture of X-ray images. These X-ray images provide the detailed penetrating anatomical guideposts that greatly enhance the localization of the in vivo optical or radioisotopic molecular imaging agents.

The product line consists of the Kodak Image Station In-Vivo F and the Kodak Image Station In-Vivo FX. The In-Vivo F allows for very high resolution, multi-wavelength fluorescence, luminescence and radioisotopic imaging in small animals. The In-Vivo FX includes all of the capabilities of the In-Vivo F and the high-resolution X-ray Imaging Module using a Radiographic (X-ray) Imaging Screen.

For both radiographic and radioisotopic imaging, patented Kodak phosphor screens coupled to speed-enhancing interference optics efficiently convert the ionizing radiation into light. The light is emitted by the screens and captured by the charge-coupled device (CCD) camera to form the image. Two different screen assemblies are available. One is optimized for the high-energy radioisotopes such as 111In, 99Tc and 18F, and the other is optimized for the low-energy, high-resolution requirements of X-ray imaging.


Multimodal imaging operation
The Kodak Image Station In-Vivo F and FX systems use the same operation and hardware for optical imaging of an animal (or multiple animals) immobilized and positioned in the animal chamber directly above the imaging chamber window (Fig. 1a). For fluorescence, excitation light from a high-intensity lamp is directed through the selected excitation filter to the animal. Fluorescence from the imaging agent inside the animal is then emitted and separated from the excitation light as it passes through the patented Kodak Wide Angle emission filter. The fluorescence enters the 10 zoom lens and is focused onto a 4 million pixel, cooled CCD. The digitized readout is efficiently interfaced to a personal computer (Windows or Mac).

Multiple optical images of different molecular entities with different fluorescent tags can be captured in the same animal by simply selecting different filters and capturing additional images. In Time-Lapse mode, multiple images can be captured in the same session to track the bio-distribution of the imaging agent.

Once the desired optical images are captured, the radiographic (Xray) phosphor screen can be moved into the imaging field by simply sliding the screen under the animal chamber (Fig. 1b). The phosphor screen comes into close contact with the thin plastic sheet that supports the animal in the animal chamber, placing the screen essentially at the same focal plane setting used with the optical images. The image capture setting in software is switched to X-ray and the microfocus X-ray generator emits a maximum energy of 35 Kvp for the desired imaging time (typically <30 s). The X-rays are differentially absorbed by bone and soft tissue, creating a projection of the animals anatomical structure on the phosphor screen. The bright-field image of the phosphor screen is captured and digitized in the camera and read into the computer.

As the images of each modality are captured without movement of the animal and with no change in optical focus or zoom, the images can easily be merged or overlayed in the Kodak MI software for precise coregistration.


Multimodal imaging examples
Demonstration of the coregistration of fluorescence and X-ray imaging is shown in Figure 2. The mouse was injected with OsteosenseTM 750, a near-infrared fluorescent diphosphonate probe that binds to bone. This high-resolution image of the animals paw shows the fluorescent signals coming from the probe attached to the digits in the paw (Fig. 2a). The X-ray image details the bones in the digits of the animal paw (Fig. 2b), and the overlay image demonstrates the expected colocalization and the precise coregistration of these two modalities in the Kodak instrument (Fig. 2c).

Combined multiwavelength fluorescence and X-ray imaging is shown in Figure 3. We injected three different fluorescently tagged imaging agents subcutaneously into different regions of the mouse abdomen. Fluorescence imaging with different filter sets appropriate for each fluorochrome was followed by X-ray imaging. The four images, representing the three different fluorescent channels and the X-ray image, were easily contrasted and pseudocolored in Kodak MI 4.0 software and merged in Adobe Photoshop.

The image in Figure 4 demonstrates the combination of radioisotope 18F imaging (typically used in positron emission tomography (PET) imaging) with X-ray imaging. The mouse was injected with [18F] fluordeoxyglucose (FDG) PET and imaged with the Kodak Image Station In-Vivo FX using the radioisotopic imaging screen for 8 min with the camera in the highest-binning state. The image was contrasted and overlayed on the subsequent X-ray image to show the localization of the isotope in the heart of the animal.


Conclusion
Kodak has developed and commercialized powerful multimodal in vivo imaging systems that greatly enhance the localization of molecular signals in live animals. These systems are now used by top academic, biotechnology and pharmaceutical research institutes worldwide. The flexibility of the system allows the combination and coregistration of multiple wavelengths and multiple modalities of imaging including optical, radioisotopic and radiographic imaging. Several studies are now in progress that will further detail the utility of combining, coregistering and performing the appropriate analysis of the multiple imaging modalities provided by the Kodak Image Station In-Vivo F/FX systems.


1. Mahmood, U. & Weissleder, R. Near-infrared optical imaging of proteases in cancer. Mol. Cancer Ther. 2, 489496 (2003).

For more information contact: Kodak Molecular Imaging Systems 4 Science Park New Haven, CT 06511 william.mclaughlin@kodak.com


William McLaughlin & Douglas Vizard
Kodak Molecular Imaging Systems, 4 Science Park, New Haven, Connecticut 06511, USA. Correspondence should be addressed to W.M. (william.mclaughlin@kodak.com).


back to top


'"/>

Source:


Page: All 1 2 3 4 5 6

Related biology technology :

1. A new wide field-of-view confocal imaging system and its applications in drug discovery and pathology
Post Your Comments:
(Date:7/30/2015)... July 30, 2015   Senomyx , Inc. (NASDAQ: ... science technologies to discover, develop, and commercialize novel flavor ... today reported financial results for the second quarter 2015. ... 2015, we remain on track to achieve our commercial ... Executive Officer of the Company. "Since our last quarterly ...
(Date:7/30/2015)... ... July 30, 2015 , ... As part of its 2015 growth plan and as a follow ... service business units, Whitehouse Laboratories is pleased to announce that it has begun construction ... Center of Excellence and will be strictly dedicated to basic USP 51, USP 61, and ...
(Date:7/29/2015)... 2015 US-Australian drug discovery company, Novogen Limited ... is committed to progressing its ground-breaking technology platforms to ... to ensure the Company delivers the best value for ... Ross , said the Company currently had an extensive ... discovery programs and academic partnerships and initiatives, and he ...
(Date:7/29/2015)... (PRWEB) , ... July 29, 2015 , ... ... manufacturer and supplier, announces the launch of their 2nd generation cell therapy POD® ... current miniPOD CT, but it also represents a new POD® design. , ...
Breaking Biology Technology:SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 2SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 3SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 4SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 5SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 6SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 7SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 8SENOMYX ANNOUNCES SECOND QUARTER 2015 FINANCIAL RESULTS 9Whitehouse Labs Formally Announces Plans to Open a Microbiological Laboratory 2Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 2Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 3Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 4Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 5Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 6Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 7Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 8Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 9Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 10G-CON Manufacturing Launches Their 2nd Generation Cell Therapy Cleanroom POD® 2G-CON Manufacturing Launches Their 2nd Generation Cell Therapy Cleanroom POD® 3
... Surveillance System Detects ... Emerging Pattern, ... hours,on a recent Friday, 20 people arrived, one by one, for ... various,gastrointestinal symptoms, including nausea and diarrhea., A coincidence? Or the ...
... CHAPEL HILL, N.C., May 22 Pharmaceutical and biotech,companies ... Assurance (QA) functions. This benchmarking study will help R&D,Quality ... Optimizing limited QA staff resources so that they have ... Optimizing services in regards to the FDA,s Risk-Bases method ...
... investor ... conference call, ... of BioElectronics Corporation (Pink Sheets: BIEL), the,developer of ActiPatch, an ... delivers pulsed,electromagnetic therapy, today issued the following summary of its ...
Cached Biology Technology:E. coli Outbreak in New Jersey? 2E. coli Outbreak in New Jersey? 3Best Practices in Quality Assurance and Risk-Based Approach for the Biopharmaceutical Industry 2BioElectronics Corporation - Substantial International Expansion Producing Sustained Revenue Growth-Company Reaches Monthly Break Even 2BioElectronics Corporation - Substantial International Expansion Producing Sustained Revenue Growth-Company Reaches Monthly Break Even 3BioElectronics Corporation - Substantial International Expansion Producing Sustained Revenue Growth-Company Reaches Monthly Break Even 4BioElectronics Corporation - Substantial International Expansion Producing Sustained Revenue Growth-Company Reaches Monthly Break Even 5BioElectronics Corporation - Substantial International Expansion Producing Sustained Revenue Growth-Company Reaches Monthly Break Even 6BioElectronics Corporation - Substantial International Expansion Producing Sustained Revenue Growth-Company Reaches Monthly Break Even 7BioElectronics Corporation - Substantial International Expansion Producing Sustained Revenue Growth-Company Reaches Monthly Break Even 8
(Date:7/23/2015)... DUBLIN , July 23, 2015 ... the addition of the "Global Outlook of ... their offering. The global biometrics ... both public and commercial applications owing to the ... will witness a transformation that enhances the growth ...
(Date:7/13/2015)... July 13, 2015 Synaptics Inc. (NASDAQ: ... interface solutions, today announced sampling of ClearPad ® ... driver integration (TDDI) product targeting smartphones and tablets. ... combine Synaptics , best-in-class touch controller IP ... technology developed in the company,s Japan Design Center. ...
(Date:7/9/2015)... , July 9, 2015  Synaptics ... developer of human interface solutions, today announced ... industry,s first fully hardware encapsulated fingerprint sensor ... authentication technology is literally off the grid, ... biometric matching within the fingerprint sensor to ...
Breaking Biology News(10 mins):Global Outlook of the Biometrics Industry 2015 2Global Outlook of the Biometrics Industry 2015 3Synaptics Announces Sampling of Second Generation TDDI Solutions 2Synaptics Announces Sampling of Second Generation TDDI Solutions 3Synaptics Announces World's First Match-in-Sensor Fingerprint Authentication Technology 2Synaptics Announces World's First Match-in-Sensor Fingerprint Authentication Technology 3
... is available in French . , Montreal, November ... poisoning, may be a thing of the past. New findings ... Institute for Agronomic Research (INRA), involving the Universit de Montral ... bacterium is able to survive in the competitive environment ...
... WALTHAM, MA November 28, 2010 ... targeted covalent drugs, has published research in ... irreversible inhibition of a viral protease using a ... "Selective Irreversible Inhibition of a Protease by Targeting ...
... the Advancement of Science has chosen Arizona State University,s ... education, to receive the Science Prize for ... prize, established to "encourage innovation and excellence in education, ... by students, teachers, and the public," recognizes the website,s ...
Cached Biology News:Will this be the end of hamburger disease? 2First-ever covalent irreversible inhibition of a protease central to hepatitis C infection 2ASU’s Ask A Biologist website wins prestigious SPORE prize 2ASU’s Ask A Biologist website wins prestigious SPORE prize 3
...
... Although the mixed TAMRA isomers are ... isomers are increasingly preferred for labeling peptides ... in HPLC purification that is often required ... often used than 6-TAMRA for labeling peptides ...
Rabbit polyclonal to GPCR G2A ( Abpromise for all tested applications). entrezGeneID: 29933 SwissProtID: Q9UNW8...
Alkali soluble casein is the recommended blot blocking reagent for use with the HisTag Monoclonal Antibody (Novagen) on Western blots....
Biology Products: